Taking Ozempic or Wegovy? New Research Points to a Promising Breast Health Benefit

For many women, GLP-1 medications have opened the door to better health.

Medications commonly known by names such as Ozempic and Wegovy are helping people manage their weight, improve blood sugar control, reduce appetite, and feel more confident about their long-term wellness.

Now, researchers are exploring another potentially important benefit.

A large Penn Medicine study found that women who had been prescribed GLP-1 medications experienced approximately 30% fewer breast cancer diagnoses than comparable women who had not been prescribed these medications. The findings are especially encouraging because it suggests that the benefits of improving metabolic health may reach beyond the number on the scale.

While additional research is needed to understand exactly how GLP-1 medications may influence breast health, this study offers women another positive reason to feel encouraged about taking control of their health.

A Welcome and Encouraging Discovery for Women

The Penn Medicine study included more than 111,000 women between the ages of 45 and 80 who had undergone breast imaging.

Researchers compared women who had been prescribed GLP-1 medications with women who had not used them.

In the complete study group, the women prescribed GLP-1 medications had 35.1% lower odds of being diagnosed with breast cancer.

Researchers then created a more closely matched group. Women were compared based on age, race, ethnicity, body mass index, breast density, and diabetes status.

Even after accounting for these important differences, the women prescribed GLP-1 medications had 30.5% lower odds of receiving a breast cancer diagnosis. For women already taking a GLP-1 medication for diabetes or medical weight management, this is promising news.

The study does not yet allow doctors to prescribe GLP-1 medications specifically for breast cancer prevention. However, it gives researchers a strong reason to continue investigating whether these medications may provide meaningful breast health benefits.

GLP-1 Benefits May Extend Beyond Weight Loss

Most women first hear about GLP-1 medications because of their ability to support weight loss or help manage type 2 diabetes.

These medications work with natural processes in the body that affect:

• Appetite
• Digestion
• Blood sugar
• Insulin response
• Inflammation
• Metabolic health

These improvements can help women feel better, move more comfortably, become more active, and reduce some of the long-term health complications associated with excess weight.

The new research suggests that these positive changes may also create a healthier internal environment for breast tissue.

Researchers are especially interested in GLP-1 medications because they affect several biological pathways connected to the development of cancer. According to Penn Medicine, their influence on weight, inflammation, metabolism, and other cellular processes may work together to help discourage breast cancer development. A Healthier Weight Can Support Healthier Breasts

Maintaining a healthy weight is about much more than appearance.

It can support heart health, mobility, sleep, energy, blood sugar control, hormone balance, and overall quality of life. It may also be an important part of supporting long-term breast health, especially after menopause.

After menopause, body fat becomes a meaningful source of estrogen. Because estrogen can encourage the growth of certain types of breast cancer, reducing excess body fat may help reduce some hormone-related influences on breast tissue.

This may be one reason researchers observed fewer breast cancer diagnoses among women prescribed GLP-1 medications.

It is possible that the benefit comes partly from weight loss. It is also possible that the medications provide additional benefits through improved insulin regulation, reduced inflammation, or a combination of several healthy changes.

The important message is positive: improvements in metabolic health may also support breast health.

Lower Inflammation May Be Another Valuable Benefit

Inflammation is part of the body’s natural healing and immune response.

However, long-term, low-level inflammation can place stress on the body and affect how cells grow, repair themselves, and communicate.

Excess body fat can contribute to chronic inflammation. GLP-1 medications may help reduce this inflammation through several different biological pathways.

Penn Medicine researchers believe these anti-inflammatory effects, together with metabolic and weight-related improvements, may help explain the lower number of breast cancer diagnoses seen among GLP-1 users. This is another reason the research is so interesting.

Rather than affecting only one part of the body, GLP-1 medications may support several systems connected to a woman’s overall wellness.

What This Means If You Already Take Ozempic or Wegovy

Women who are already taking a GLP-1 medication for an appropriate medical reason can view this study as an encouraging development.

Your medication may already be helping you:

• Reach a healthier weight
• Manage blood sugar
• Reduce stress on your joints
• Become more physically active
• Improve metabolic health
• Feel more in control of your wellness

The possibility of an additional breast health benefit makes the research even more hopeful.

However, every woman is different. The effects of medication can depend on her health history, age, weight, genetics, hormonal status, lifestyle, and other medications.

Continue taking your medication exactly as prescribed and discuss any questions with the healthcare professional managing your treatment.

There is no need to discontinue a GLP-1 medication because of this study. Likewise, women should not begin taking one solely to prevent breast cancer until clinical trials provide clearer guidance.

The takeaway is not one of fear or uncertainty. It is one of optimism and progress.

This Research May Create New Options for Women

Breast cancer research has traditionally focused heavily on finding and treating cancer after it develops.

Those advances have saved many lives. Researchers are now also placing greater emphasis on preventing breast cancer before it begins.

The new GLP-1 findings may help open another path forward.

Penn Medicine researchers are working toward a multisite clinical trial to determine whether GLP-1 medications can help lower breast cancer incidence among women with higher-than-average risk. The planned research may also include women who have previously had breast cancer. Future studies may help doctors understand:

• Which women may benefit the most
• Whether certain GLP-1 medications offer greater benefits
• How long a woman may need to use the medication
• How weight loss influences the results
• Whether GLP-1 medications affect certain breast cancer types differently
• Whether they may support the health of breast cancer survivors

This does not mean GLP-1 medications are replacing existing breast cancer treatments or prevention strategies.

It means women may eventually have another helpful option—and more options are always worth pursuing.

What About Women Who Have Already Had Breast Cancer?

Women who have completed breast cancer treatment often want to know what they can do to support their future health.

Many are interested in improving their weight, energy, mobility, blood sugar, cardiovascular health, and overall quality of life.

The Penn Medicine study did not specifically establish that GLP-1 medications prevent breast cancer from returning. However, researchers are interested in studying women with a previous history of the disease as part of future clinical research. This makes this an especially important area to watch.

Women who have had breast cancer may still be candidates for GLP-1 medications when there is an appropriate medical reason. The decision should be personalized and coordinated with the physicians involved in their care.

A woman taking hormone therapy, receiving chemotherapy, preparing for surgery, or managing treatment-related nutritional concerns should make sure her breast cancer team knows about all medications she is using.

GLP-1 Medications Are One Part of a Complete Wellness Plan

A medication can be a valuable tool, but it works best as part of a complete approach to health.

Women taking GLP-1 medications can support their results by focusing on:

• Nutritious, protein-rich foods
• Regular movement and strength-building exercise
• Maintaining muscle while losing weight
• Good sleep
• Limiting alcohol
• Keeping scheduled mammograms
• Paying attention to new breast changes
• Maintaining regular medical appointments

Breast screening remains important even when a woman is losing weight and improving her overall health.

A GLP-1 medication does not replace mammograms, breast examinations, MRI screening when recommended, genetic counseling, or evaluation of a new lump or breast change.

Instead, it may become one more helpful part of a larger breast wellness strategy.

Frequently Asked Questions About GLP-1 Medications and Breast Health

Can Ozempic or Wegovy benefit breast health?

A large observational study found that women prescribed GLP-1 medications experienced approximately 30% fewer breast cancer diagnoses than comparable women who were not prescribed them. Researchers are now planning additional studies to understand whether the medications directly contribute to this encouraging result. Does Ozempic prevent breast cancer?

Ozempic is not currently prescribed as a breast cancer prevention medication. However, emerging research suggests that GLP-1 medications may be associated with a lower incidence of breast cancer.

Clinical trials will help researchers determine whether the medications provide a direct protective benefit and which women may benefit most.

Can weight loss improve breast health?

Achieving and maintaining a healthier weight can support many areas of a woman’s health. Because excess body weight after menopause is connected to hormonal, inflammatory, and metabolic changes, healthy weight management may also support long-term breast wellness.

Should I continue my GLP-1 medication?

Continue taking medication as directed by the clinician who prescribed it. Do not discontinue or change your medication based solely on a news report or online article.

The new research provides an encouraging reason for continued scientific study, not a reason to make medication changes without medical guidance.

Can a breast cancer survivor take a GLP-1 medication?

Some breast cancer survivors may be appropriate candidates for GLP-1 medications. The decision should be personalized based on current treatment, nutritional health, medical history, diabetes status, weight, and other medications.

Discuss the medication with both the prescribing clinician and your breast cancer team.

Should I tell my breast surgeon that I take Ozempic or Wegovy?

Yes. Your breast surgeon and anesthesia team should know about every medication you use, including GLP-1 medications.

Your surgical team will provide individualized instructions about medication use before and after surgery.

A Positive Step Forward for Women’s Health

GLP-1 medications have already changed the lives of many women by helping them improve their weight, blood sugar, mobility, confidence, and overall health.

The possibility that these medications may also support breast health is an exciting and hopeful development.

In a study of more than 110,000 women, those prescribed GLP-1 medications experienced approximately 30% fewer breast cancer diagnoses than comparable women who were not prescribed the medications. Researchers still have important questions to answer, but the direction is encouraging.

For women already using GLP-1 medications appropriately, the message is positive: the health improvements you are making today may provide benefits that reach further than previously understood.

Continue caring for your whole health. Keep your breast screening appointments. Pay attention to changes in your body. Ask questions, stay informed, and take pride in every healthy step forward.

Supporting Your Breast Health at Every Step

The encouraging research surrounding GLP-1 medications is another reminder that improving one area of health may positively influence the body in ways we are still learning to understand. However, even as research advances, regular breast screening and prompt evaluation of any new concern remain essential.

Continue attending recommended mammograms, paying attention to changes in your breasts, and speaking with a qualified breast specialist if you receive an abnormal imaging result or notice something unusual.

Should a breast concern or diagnosis arise, it is also important to know that women often have more treatment options than they initially realize. Modern breast cancer surgery can focus not only on removing the cancer effectively, but also on preserving or restoring the natural appearance of the breast whenever medically appropriate.

Dr. Jean-Claude Schwartz specializes in breast cancer surgery and immediate reconstruction, including breast-conserving procedures and advanced oncoplastic techniques. His approach helps women understand the full range of surgical options available so they can make informed decisions based on both their health and personal goals.

You can learn more about available breast cancer surgery and reconstruction procedures, view the practice’s breast surgery before-and-after gallery, or review helpful information for patients traveling from outside the Atlanta area.

If you are facing an abnormal mammogram, a new breast cancer diagnosis, or questions about your surgical options, schedule a breast surgery consultation with Dr. Schwartz to receive a personalized evaluation and learn which approaches may be appropriate for you.

Disclaimer: This article is provided for general educational purposes and does not replace individualized medical advice, diagnosis, or treatment. Always consult your prescribing clinician before beginning, discontinuing, or changing a medication.

Jean-Claude Schwartz, MD, PhD – Breast Cancer and Reconstructive Surgeon

Dr. Schwartz is a highly respected national leader in oncoplastic breast surgery. He is a preferred provider for the majority of insurance plans and is highly recommended by insurance companies and patients alike. By performing most of his surgeries in an outpatient ambulatory center, he saves his patients on hospital costs, co-pays, and more.

As a breast surgeon and reconstructive surgeon, he performs most mastectomies and reconstructions in one surgery, saving his patients time and money by seeing only one expert, paying only one set of deductibles and co-pays, and most importantly, reducing time spent in the operating room while providing unparalleled results.

Dr. Schwartz and his entire staff specialize in breast surgeries only, and as such, are highly experienced in dealing with insurance companies. They can provide guidance and invaluable information to women undergoing breast reconstructive surgeries. Additionally, as part of the Northside Hospital system, patients benefit beyond Dr. Schwartz’s practice.

Dr. Schwartz is always accepting new patients diagnosed with breast cancer and makes it his priority to see them immediately, despite his very busy schedule.

Click to SCHEDULE YOUR CONSULTATION TODAY!

470-322-6757